Michigan Institute for Clinical and Health Research (MICHR)

密歇根临床与健康研究所 (MICHR) 是一个催化中心，对 将研究科学转化为临床护理和卫生政策的创新改进。我们的 目标是增强密歇根大学内外的研究人员和研究社区的能力 （密歇根大学），对地方、区域、国家和全球范围内的健康产生积极影响。我们将实现 通过以下总体具体目标来实现这一目标： 1) 创新和实施有效的教育 培养一支熟练且多样化的转化研究队伍的方法； 2）促进有效的研究 与社区伙伴合作，加速转化造福社会的突破； 3）推广 跨转化阶段和跨生命周期的临床和转化研究； 4）推进研究 实现更高质量的临床和转化研究的方法和流程； 5）开发， 展示和传播信息学创新，促进生物医学发现转化为 健康影响。 MICHR 渴望对密歇根大学产生独特的、实质性的、可衡量的和可识别的影响 以及我们社区的健康。为了高效地实现这一目标，我们严格评估了预 整个机构研究领域的现有优势和新兴机遇。 MICHR 将加强 并与校园内的主要研究和监管单位建立合作伙伴关系，以开发高效的管道 加速发现的转化和实施，同时促进跨领域签名 吸引翻译各个阶段的研究人员和社区成员参与的举措。

The Michigan Institute for Clinical & Health Research (MICHR) is a catalytic hub that significantly impacts the translation of investigative science into innovative improvements in clinical care and health policy. Our objective is to empower researchers and research communities within and outside the University of Michigan (U-M), creating a positive impact on health across local, regional, national, and global scales. We will achieve this objective through the following overarching specific aims: 1) Innovate and implement effective educational approaches to developing a skilled and diverse translational research workforce; 2) Catalyze effective research with community partnerships to accelerate the translation of breakthroughs that benefit society; 3) Promote clinical and translational research across translational phases and across the lifespan; 4) Advance research methods and processes that enable higher quality clinical and translational research; 5) Develop, demonstrate, and disseminate informatics innovations that facilitate the translation of biomedical discoveries to health impact. MICHR aspires to have a unique, substantial, measurable, and recognizable impact on U-M and the health of our communities. In order to achieve this with efficiency, we have critically evaluated pre- existing strengths and emerging opportunities across the institutional research landscape. MICHR will enhance and develop partnerships with major research and regulatory units on campus to develop an efficient pipeline that accelerates the translation and implementation of discoveries while also promoting cross-cutting signature initiatives that engage research and community members from all phases of translation.